Atropine 1 MG/ML vialml
Ended Awarded
- Contract number
- SPE2DX25F4NKM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $2,111
Award facts
- Contract value 100% obligated
- $2,111.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Atropine 1 mg/mL vials under a firm fixed-price contract valued at $2,111.43. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The award involves no set-aside designation and was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, fulfills this order as part of its comprehensive role supplying pharmaceutical products and medical supplies to military and veteran healthcare systems. The parent IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Atropine—an emergency medication used primarily for nerve agent and organophosphate poisoning treatment—exemplifies the company's provision of essential pharmaceutical products supporting military medical readiness. The contract has an ultimate completion date of August 12, 2025.
Quick answers
Who was awarded contract SPE2DX25F4NKM?
SPE2DX25F4NKM was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 11, 2025.
How much is contract SPE2DX25F4NKM worth?
The government has obligated $2,111 on SPE2DX25F4NKM.
Is contract SPE2DX25F4NKM an order under another contract?
Yes. SPE2DX25F4NKM is a delivery order under SPE2DX15D2223, an indefinite delivery contract.
Was contract SPE2DX25F4NKM competed?
The extent of competition for SPE2DX25F4NKM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award